Filters
Other countries
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Invitae Congenital Disorders of Glycosylation Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 203 | 152 |
|
Invitae Congenital Myasthenic Syndrome Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 38 | 21 |
|
Dystroglycanopathy via the GMPPB Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Congenital Muscular Dystrophy (CMD) Panel PreventionGenetics, part of Exact Sciences United States | 34 | 28 |
|
Comprehensive Brain Malformation Panel Genetic Services Laboratory University of Chicago United States | 37 | 131 |
|
Congenital muscular dystrophy and LGMD panel. 42-gene NGS panel. Genologica Medica Spain | 96 | 42 |
|
Girdle muscular dystrophy. NGS panel of 39 genes. Genologica Medica Spain | 84 | 39 |
|
Neuronal migration disorder panel. NGS panel of 58 genes. Genologica Medica Spain | 110 | 57 |
|
Muscular dystrophy-dystroglycanopathy, type B: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 7 | 7 |
|
Neuromuscular Disorders NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 233 | 144 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.